References
- 1
Essentials of Glycobiology
Varki A.
Cummings R.
Esko J.
Freeze H.
Hart G.
Marth J.
Cold Spring Harbor Lab. Press;
Cold Spring Harbor:
1999.
-
2a
Gabius H.-J.
Eur. J. Biochem.
1997,
243:
543
-
2b
Lis H.
Sharon N.
Chem. Rev.
1998,
98:
637
- 3
Lee YC.
Lee RT.
Acc. Chem. Res.
1995,
28:
321
- 4
Roy R.
Baek M.-G.
Rittenhouse-Olson K.
J. Am. Chem. Soc.
2001,
123:
1809
- 5
Matsuda A.
Doi T.
Tanaka H.
Takahashi T.
Synlett
2001,
1101
- 6 Protected carbohydrate cluster library synthesis on solid-support, see: Wittmann V.
Seeberger S.
Angew. Chem. Int. Ed.
2000,
39:
4348
-
7a
Izumi M.
Fukase K.
Kusumoto S.
Synlett
2002,
1409
-
7b
Fürst M.
Rück-Braun K.
Synlett
2002,
1991
-
7c
Fukase Y.
Fukase K.
Kusumoto S.
Tetrahedron Lett.
1999,
40:
1169
- 8
Nicolaou KC.
Skokotas G.
Maligres P.
Zuccarello G.
Schweiger EJ.
Toshima K.
Wendeborn S.
Angew. Chem., Int. Ed. Engl.
1989,
28:
1272
- 10
Freedman HH.
Dubuois RA.
Tetrahedron Lett.
1975,
3251
- 12 In
Solid-Phase Synthesis and Combinatorial Technologies
Seneci P.
John Wiley and Sons, Inc.;
New York:
2000.
Chap. 1.
p.33
- 13
Kaiser E.
Colescott RL.
Bossinger CD.
Cook PI.
Anal. Biochem.
1970,
34:
595
- 14
Grangjean C.
Rommens C.
Gras-Masse H.
Melnyk O.
Tetrahedron Lett.
1999,
40:
7235
- 22
Condaminet B.
Péguet-Navarro J.
Stahl PD.
Dalbeiz-Gautheir C.
Schmitt D.
Bertheir-Vergens O.
Eur. J. Immunol.
1998,
28:
3541
- 23
Weis WI.
Taylor ME.
Drickamer K.
Immunol. Rev.
1998,
163:
19
9 Alcohol 3 was prepared from glycerol over 6 steps: 1. pivaloylation of two 1°-hydroxyl groups; 2. protection of the remained hydroxyl group with THP group; 3. alkaline hydrolysis; 4. di-mesylation; 5. di-azidation; 6. acid-catalyzed hydrolysis.
11 Commercially available from Argonaut Technologies, San Carlos, California: http://www.argotech.com.
15 The characteristic IR absorption was observed at 2092, 2056, 2018 cm-1.
16 The cleavage product was filtered through the reverse phase C-18 column (Varian Bond Elut C18, 500 mg). Spectral data of 9: 1H NMR (400 MHz, D2O, 30 °C): δ = 2.78 (dd, 4 H, J = 6.3, 6.3 Hz), 3.20 (dd, 2 H, J = 7.2, 14.0 Hz), 3.27-3.33 (m, 2 H), 3.30 (s, 4 H), 3.45 (dd, 2 H, J = 7.7, 9.7 Hz), 3.57 (dd, 2 H, J = 3.4, 9.7 Hz), 3.58-3.62 (m, 2 H), 3.65-3.71 (m, 4 H), 3.79 (dt, 2 H, J = 6.3, 10.6 Hz), 3.80 (m, 1 H), 3.85 (brd, 2 H, J = 3.4 Hz), 4.01 (dt, 2 H, J = 6.3, 10.6 Hz), 4.34 (d, 2 H, J = 7.7 Hz, anomeric). 13C NMR (67.8 MHz, D2O, 30 °C): δ = 34.2, 37.8, 45.5, 63.6, 71.0, 71.3, 71.5, 73.4, 75.4, 77.9, 105.6, 165.2, 175.6. MS (ESI-TOF): 651 [M + H]+.
17 The cleavage product was filtered through the reverse phase C-18 column (Varian Bond Elut C18, 500 mg). Spectral data of 10: 1H NMR (400 MHz, D2O, 30 °C): δ = 2.56 (br s, 4 H), 2.85 (dd, 4 H, J = 5.3, 6.3 Hz), 3.33 (dd, 4 H, J = 6.3, 14.0 Hz), 3.36 (s, 8 H), 3.43 (dd, 4 H, J = 4.4, 14.0 Hz), 3.50 (dd, 4 H, J = 7.7, 9.7 Hz), 3.61-3.68 (m, 8 H), 3.70-3.80 (m, 8 H), 3.82-3.88 (m, 6 H), 3.90 (br d, 4 H, J = 2.9 Hz), 3.97 (quintet, 1 H, J = 3.9 Hz), 4.07 (dt, 4 H, J = 6.3, 10.6 Hz), 4.31 (br s, 4 H), 4.40 (d, 4 H, J = 7.7 Hz, anomeric). 13C NMR (67.8 MHz, D2O, 30 °C): δ = 28.1, 34.8, 43.1, 60.1, 63.6, 70.6, 71.2, 71.3, 71.4, 73.3, 73.4, 75.5, 77.9, 78.0, 80.8, 86.6, 105.6, 175.5. MS (ESI-TOF): 1455.5 [M + Na]+.
18 All products were confirmed by ESI-TOF mass spectra and the complete assignments of chemical shifts (1H NMR) based on 1H-1H COSY spectra.
19 FITC-ManBSA was prepared by coupling of Fluorescein isothiocyanate (FITC) with coupled with mannosylated bovine serum albumine (ManBSA) in carbonate buffer (pH 9.5) at r.t. Purification of FITC-ManBSA was achieved by purified by gel-filteration on Sephedex G-25 using phosphate buffered saline as an eluent.
20 Dimer-CM and tetramer-CM could not be examined because of their less solubility in water.
21 FITC-ManBSA derived mean fluorescence intensity of PEMs was analyzed cytofluorimetrically by gating viable CD4
+ population. The values are means ± SD from three separate experiments.